BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24285729)

  • 1. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
    Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
    Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
    Zhang F; Fan Q; Ren K; Andreassen PR
    Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
    Sy SM; Huen MS; Chen J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism for the suppression of homologous recombination in G1 cells.
    Orthwein A; Noordermeer SM; Wilson MD; Landry S; Enchev RI; Sherker A; Munro M; Pinder J; Salsman J; Dellaire G; Xia B; Peter M; Durocher D
    Nature; 2015 Dec; 528(7582):422-6. PubMed ID: 26649820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1-Dependent and Independent Recruitment of PALB2-BRCA2-RAD51 in the DNA Damage Response and Cancer.
    Foo TK; Xia B
    Cancer Res; 2022 Sep; 82(18):3191-3197. PubMed ID: 35819255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
    Zhao W; Steinfeld JB; Liang F; Chen X; Maranon DG; Jian Ma C; Kwon Y; Rao T; Wang W; Sheng C; Song X; Deng Y; Jimenez-Sainz J; Lu L; Jensen RB; Xiong Y; Kupfer GM; Wiese C; Greene EC; Sung P
    Nature; 2017 Oct; 550(7676):360-365. PubMed ID: 28976962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair.
    Park JY; Singh TR; Nassar N; Zhang F; Freund M; Hanenberg H; Meetei AR; Andreassen PR
    Oncogene; 2014 Oct; 33(40):4803-12. PubMed ID: 24141787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
    Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
    Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
    Prakash R; Zhang Y; Feng W; Jasin M
    Cold Spring Harb Perspect Biol; 2015 Apr; 7(4):a016600. PubMed ID: 25833843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.
    Fernandes PH; Saam J; Peterson J; Hughes E; Kaldate R; Cummings S; Theisen A; Chen S; Trost J; Roa BB
    Cancer; 2014 Apr; 120(7):963-7. PubMed ID: 24415441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.
    Johnson N; Johnson SF; Yao W; Li YC; Choi YE; Bernhardy AJ; Wang Y; Capelletti M; Sarosiek KA; Moreau LA; Chowdhury D; Wickramanayake A; Harrell MI; Liu JF; D'Andrea AD; Miron A; Swisher EM; Shapiro GI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17041-6. PubMed ID: 24085845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage.
    Krais JJ; Wang Y; Patel P; Basu J; Bernhardy AJ; Johnson N
    Nat Commun; 2021 Aug; 12(1):5016. PubMed ID: 34408138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.
    Hartford SA; Chittela R; Ding X; Vyas A; Martin B; Burkett S; Haines DC; Southon E; Tessarollo L; Sharan SK
    PLoS Genet; 2016 Aug; 12(8):e1006236. PubMed ID: 27490902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated in silico approach to analyze the involvement of single amino acid polymorphisms in FANCD1/BRCA2-PALB2 and FANCD1/BRCA2-RAD51 complex.
    Doss CG; Nagasundaram N
    Cell Biochem Biophys; 2014 Nov; 70(2):939-56. PubMed ID: 24817641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasticity of BRCA2 function in homologous recombination: genetic interactions of the PALB2 and DNA binding domains.
    Siaud N; Barbera MA; Egashira A; Lam I; Christ N; Schlacher K; Xia B; Jasin M
    PLoS Genet; 2011 Dec; 7(12):e1002409. PubMed ID: 22194698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
    Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
    Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for recruitment of BRCA2 by PALB2.
    Oliver AW; Swift S; Lord CJ; Ashworth A; Pearl LH
    EMBO Rep; 2009 Sep; 10(9):990-6. PubMed ID: 19609323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.
    Downs B; Kim YC; Xiao F; Snyder C; Chen P; Fleissner EA; Becirovic D; Wen H; Sherman S; Cowan KH; Lynch HT; Wang SM
    Breast Cancer Res Treat; 2015 May; 151(1):219-24. PubMed ID: 25833210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response.
    Simhadri S; Vincelli G; Huo Y; Misenko S; Foo TK; Ahlskog J; Sørensen CS; Oakley GG; Ganesan S; Bunting SF; Xia B
    Oncogene; 2019 Mar; 38(10):1585-1596. PubMed ID: 30337689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.